A compound having selective modulating activity at the alpha 2B and or alpha 2C adrenergic receptor subtypes is represented by the general Formula (1): wherein R
1
-R
6
is independently selected from the group consisting of H, C
1-6
alkyl, halogen, CH
2
OH, CH
2
N(R
7
)
2
)CH
2
CN, C(O)R
8
, CF
3
, and aryl; wherein R
7
is H or C
1-6
alkyl; and R
8
is H, C
1-6
alkyl or aryl. The compounds of Formula (1) can be incorporated in pharmaceutical compositions and used in methods of treatment of alpha 2 receptor mediated diseases and conditions.
具有选择性调节α2B和/或α2C
肾上腺素受体亚型的化合物由通用式(1)表示:其中R1-R6独立地选自H,C1-6烷基,卤素,CH2OH,
CH2N(R7)2)CH2CN,C(O)R8,
CF3和芳基的群;其中R7为H或C1-6烷基;R8为H,C1-6烷基或芳基。公式(1)的化合物可以被纳入制药组合物中,并用于治疗α2受体介导的疾病和病况的方法。